logo

PIRS Stock Update: Pieris Pharmaceuticals Inc’s Banking’s Market Struggles and Potential Opportunities

Pieris Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $1.52 on 03/28/23, while the lowest value for the same period was recorded at $0.14 on 12/13/23.

52-week price history of PIRS Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Pieris Pharmaceuticals Inc’s current trading price is -88.04% away from its 52-week high, while its distance from the 52-week low is 33.58%. The stock’s price range during the 52-week period has remained between $0.14 and $1.52. In the Healthcare sector, the company’s shares saw a trading volume of around 2.55 million for the day, which was evidently higher than the average daily volume of 0.58 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Pieris Pharmaceuticals Inc (PIRS) has experienced a quarterly rise of 17.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.97M and boasts a workforce of 144 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1872, with a change in price of -0.0455. Similarly, Pieris Pharmaceuticals Inc recorded 597,829 in trading volume during the last 100 days, posting a change of -19.50%.

Examining PIRS’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for PIRS stands at 0.40. Similarly, the long-term debt-to-equity ratio is also 0.00.

PIRS Stock Stochastic Average

As of today, Pieris Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 30.11%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 26.45%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 32.98% and 38.48%, respectively.

PIRS Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -0.11%. However, over the past six months, we’ve seen a stronger performance of -43.19%. The price of PIRS fallen by 11.81% over the last 30 days. And in the last five days, it has fallen by -13.43%.